Meeting Banner
Abstract #1218

Assessment of inflammatory Component in the Mono-Iodoacetate (MIA) Model of Osteoarthritis by MRI

Thomas Kaulisch 1 , Laura Corradini 2 , and Detlef Stiller 3

1 Target Discovery Research, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Baden-Wrttemberg, Germany, 2 CNS Diseases Research, Boehringer Ingelheim Pharma GmbH & Co. KG, Baden-Wrttemberg, Germany, 3 Target Discovery Research, Boehringer Ingelheim Pharma GmbH & Co. KG, Baden-Wrttemberg, Germany

The Mono-Iodoacetate (MIA) model is an attractive tool for testing novel compounds at different stages of progressive osteoarthritis (OA) development. We characterize the inflammatory component by means of MRI-based volumetry and DCE-MRI and demonstrate treatment effects when using Celecoxib.

This abstract and the presentation materials are available to members only; a login is required.

Join Here